Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...
In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, discusses the AquaLumen, a subconjunctival bypass technology to lower IOP in patients with glaucoma.
Standalone canaloplasty and trabeculotomy can deliver meaningfully reduced IOP in the long term and require fewer topical therapy agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback